Anxiety: Drug Therapy

Encyclopedia of Neuroscience

Volumn , Issue , 2009, Pages 499-508

  Haas, C K ^a   Shekhar, A ^a   Goddard, A W ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety disorders; Anxiety drug therapy mechanisms; Anxiety pharmacotherapy; Fear circuit; Generalized anxiety disorder; Obsessive compulsive disorder; Panic disorder; Posttraumatic stress disorder; Social anxiety disorder

Indexed keywords

EID: 84862871145     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008045046-9.00377-6     Document Type: Chapter

References (33)

1. Anand A., Shekhar A. Brain imaging studies in mood and anxiety disorders: Special emphasis on the amygdala. Annals of the New York Academy of Sciences 2003, 985:370-388.
2. Asnis G.M., Kohn S.R., Henderson M., Brown N.L. SSRIs versus non-SSRIs in post-traumatic stress disorder: An update with recommendations. Drugs 2004, 64(4):383-404.
3. Blier P., Abbot F.V. Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain. Journal of Psychiatry & Neuroscience 2001, 26(1):37-43.
4. Blier P., Szabo S.T. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety. Journal of Clinical Psychiatry 2005, 66(supplement 8):30-40.
5. Boone M.L., McNeil W., Masia C.L., et al. Multimodal comparisons of social phobia subtypes and avoidant personality disorder. Journal of Anxiety Disorders 1999, 13:271-292.
6. Brawman-Mintzer O. Pharmacologic treatment of generalized anxiety disorder. Psychiatry Clinics of North America 2001, 24(1):119-137.
7. Bruce S.E., Vasile R.G., Goisman R.M., et al. Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?. American Journal of Psychiatry 2003, 160:1432-1438.
8. Charney D., Nestler E. Neurobiology of Mental Illness 2004, Oxford University Press, Oxford, UK. 2nd edn.
9. Davidson J.R.T. Long-term treatment and prevention of post-traumatic stress disorder. Journal of Clinical Psychiatry 2004, 65(supplement 1):44-48.
10. Davidson J.R.T. Use of benzodiazepines in social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder. Journal of Clinical Psychiatry 2004, 65(supplement 5):29-33.
11. Davidson J.R.T. Pharmacotherapy of social anxiety disorder: What does the evidence tell us?. Journal of Clinical Psychiatry 2006, 67(supp 12):20-26.
12. Davis M., Myers K.M. The role of glutamate and gamma-aminobutyric acid in fear extinction: Clinical implication for exposure therapy. Biological Psychiatry 2002, 52:998-1007.
13. Garakani A., Mathew S.J., Charney D.S. Neurobiology of anxiety disorders and implications for treatment. Mount Sinai Journal of Medicine 2006, 73(7):941-949.
14. Gelpin E., Bonne O., Peri T., et al. Treatment of recent trauma survivors with benzodiazepines: A prospective study. Journal of Clinical Psychiatry 1996, 57(9):390-394.
15. Goddard A.W., Brouette T., Almai A., et al. Early coadministration of clonazepam with sertraline for panic disorder. Archives of General Psychiatry 2001, 58:681-686.
16. Goddard A.W., Charney D.S. Toward an integrated neurobiology of panic disorder. Journal of Clinical Psychiatry 1997, 58(supplement 2):4-11.
17. Goodman W.K. Selecting pharmacotherapy for generalized anxiety disorder. Journal of Clinical Psychiatry 2004, 65(supplement 13):8-13.
18. Gorman J.M. Treating generalized anxiety disorder. Journal of Clinical Psychiatry 2003, 64(supplement 2):24-29.
19. Keck P.E., Strawn J.R., McElroy S.L. Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders. Journal of Clinical Psychiatry 2006, 67(supplement 1):8-15.
20. McDougle C.J., Goodman W.K., Leckman J.F., et al. A double-blind, placebo-controlled trial of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Archives of General Psychiatry 2000, 57:794-801.
21. Mellman T.A., Bustamante V., David D., et al. Hypnotic medication in the aftermath of trauma. Journal of Clinical Psychiatry 2002, 63(12):1183-1184.
22. Morgan C.A., Krystal J.H., Southwick S.M. Toward early pharmacologic posttraumatic stress intervention. Biological Psychiatry 2003, 53:834-843.
23. Nutt D., Bell C., Masterson C., Short C. Mood and Anxiety Disorders in Children and Adolescents: A Psychopharmacological Approach 2001, Martin Dunitz, London.
24. Pallanti S., Hollander E., Biestock C., et al. Treatment non-response in OCD: Methodological issues and operational definitions. International Journal of Neuropsychopharmacology 2002, 5:181-191.
25. Pallanti S., Hollander E., Goodman W. A qualitative analysis of nonresponse: Management of treatment-refractory obsessive-compulsive disorder. Journal of Clinical Psychiatry 2004, 65(supplement 14):6-10.
26. Pitman R.K., Sanders K.M., Zusman R.M., et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biological Psychiatry 2002, 51:183-188.
27. Pollack M.H. The pharmacotherapy of panic disorder. Journal of Clinical Psychiatry 2005, 66(supplement 4):23-27.
28. Rainnie D.G., Bergeron R., Sajdyk T.J., Patil M., Gehlert D.R., Shekhar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. Journal of Neuroscience 2004, 24(14):3471-3479.
29. Roy-Byrne P.P., Craske M.G., Stein M.B. Panic disorder. Lancet 2002, 369:1023-1032.
30. Sheehan D.V. The management of panic disorder. Journal of Clinical Psychiatry 2002, 63(supplement 14):17-21.
31. Shekhar A., Truitt W., Rainnie D., Sajdyk T. Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety. Stress 2005, 8(4):209-219.
32. Stutzmann G.E., LeDoux J.E. GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: A mechanism for modulation of sensory inputs related to fear conditioning. Journal of Neuroscience 1999, 19:RC8.
33. Westenberg H.G.M., Boer J.A.D., Murphy D.L. Advances in the Neurobiology of Anxiety Disorders 1996, Wiley, New York.